Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update


Therapeutic Solutions International, Inc. (OTCMKTS:TSOIGet Rating) was the target of a significant drop in short interest in April. As of April 15th, there was short interest totalling 47,800 shares, a drop of 92.4% from the March 31st total of 626,800 shares. Based on an average daily trading volume, of 11,283,300 shares, the days-to-cover ratio is currently 0.0 days.

OTCMKTS:TSOI opened at $0.03 on Friday. The business’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.03. Therapeutic Solutions International has a 52-week low of $0.02 and a 52-week high of $0.13.

About Therapeutic Solutions International (Get Rating)

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, improve maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship products include NanoStilbene, an easily absorbed nanoemulsion of nanoparticle pterostilbene to reduce inflammatory cytokine production in cancer patients; and ProJuvenol, a synergistic blend of complex anti-aging ingredients.

Further Reading

Receive News & Ratings for Therapeutic Solutions International Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Therapeutic Solutions International and related companies with’s FREE daily email newsletter.

Source link